Skip to content

Single Dose Cefepime Versus Cefuroxime Plus Metronidazole as a Prophylactic Antibiotic During Emergency Intrapartum Cesarean Section

Single Dose Cefepime Versus Cefuroxime Plus Metronidazole as a Prophylactic Antibiotic: A Randomized Controlled Study

Status
UNKNOWN
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04009772
Enrollment
500
Registered
2019-07-05
Start date
2019-07-01
Completion date
2020-03-01
Last updated
2019-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Emergency Cesarean Section, Infection Wound

Keywords

Cefepime, Cefuroxime, Metronidazole, Cesarean, Intrapartum

Brief summary

Compare between cefepime versus routine antibiotics as a prophylactic antibiotic during emergency cesarean section in a tertiary center of obstetric care

Detailed description

This is a randomized double blinded study which compare between single dose cefepime versus cefuroxime plus metronidazole during emergency intrapartum cesarean section. Outcomes will include fever, wound infection, and urinary tract infection.

Interventions

DRUGCefepime

Antibiotic prophylaxis

DRUGCefuroxime plus Metronidazole

Antibiotic prophylaxis

Sponsors

Yasser Esmat Mohammed
CollaboratorUNKNOWN
Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* intrapartum caesarean section

Exclusion criteria

* evidence of infection

Design outcomes

Primary

MeasureTime frameDescription
Incidence of surgical site wound infectionone weekExamining the wound after one week of the surgery to detect any infection

Countries

Egypt

Contacts

Primary ContactAbdalmageed Abdalmageed
drosamast@yahoo.com.au+201007972027
Backup ContactOsama Abdalmageed
drosamast1981@gmail.com01007972027

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026